Antitumor Activity of N-Acetyl-D-glucosamine-Substituted Glycoconjugates and Combined Therapy with Keyhole Limpet Hemocyanin in B16F10 Mouse Melanoma Model

Folia Microbiologica

Volumn 55, Issue 5, 2010, Pages 528-532

  Hulikova K ^a   Grobarova V ^a   Krivohlava R ^a   Fiserova A ^a  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GLYCOCONJUGATE; HEMOCYANIN; IMMUNOLOGICAL ADJUVANT; KEYHOLE LIMPET HEMOCYANIN; KEYHOLE-LIMPET HEMOCYANIN; N ACETYLGLUCOSAMINE;

ANIMAL; ARTICLE; C57BL MOUSE; CHEMISTRY; DISEASE MODEL; DRUG COMBINATION; DRUG POTENTIATION; HUMAN; MALE; MELANOMA; MOUSE; PATHOLOGY; SKIN TUMOR; TREATMENT OUTCOME; TUMOR CELL LINE;

ACETYLGLUCOSAMINE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; GLYCOCONJUGATES; HEMOCYANIN; HUMANS; MALE; MELANOMA; MICE; MICE, INBRED C57BL; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 77958026215     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12223-010-0087-5     Document Type: Article

References (19)

1. Benson V., Grobarova V., Richter J., Fiserova A.: Glycosylation regulates NK cell-mediated effector function through PI3K pathway. Internat. Immunol., in press (2010).
2. Bezouska K.: Design, functional evaluation and biomedical applications of carbohydrate dendrimers (glycodendrimers). J. Biotechnol. 90, 269-290 (2002).
3. Bezouska K., Yuen C. T., O'Brien J., Childs R. A., Chai W., Lawson A. M., Drbal K., Fiserova A., Pospisil M., Feizi T.: Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature372, 150-157 (1994).
4. + killer cells from suicidal cell death induced by tumor cell surface ligands. Bioorg. Med. Chem. 18, 1434-1440 (2010).
5. 2-dopamine and α-adrenoreceptor antagonists in stress induced changes on immune responsiveness of mice. J. Neuroimmunol. 130, 55-65 (2002).
6. Harris J. R., Markl J.: Keyhole limpet hemocyanin (KLH): a biomedical review. Micron30, 597-623 (1999).
7. Hulikova K., Benson A., Svoboda J., Sima P., Fiserova A.: N-Acetyl-d-glucosamine-coated polyamidoamine dendrimer modulates antibody formation via natural killer cell activation. Internat. Immunopharmacol. 9, 792-799 (2009).
8. Jurincic-Winkler C. D., Metz K. A., Beuth J., Klippel K. F.: Keyhole limpet hemocyanin for carcinoma in situ of the bladder: a longterm follow-up study. Eur. Urol. 37, 45-49 (2000).
9. Krenek K., Kuldova M., Hulikova K., Stibor I., Lhotak P., Dudic M., Budka J., Pelantova H., Bezouska K., Fiserova A., Kren V.: N-Acetyl-d-glucosamine substituted calix[4]arenes as stimulators of NK cell-mediated antitumor immune response. Carbohydr. Res. 342, 1781-1792 (2007).
10. 2 adenosine receptor agonist in different mammalian species. Folia Microbiol. 54, 364-368 (2009).
11. Lanier L. L.: NK cell recognition. Ann. Rev. Immunol. 23, 225-274 (2005).
12. Lindhorst T. K., Kieburg C.: Glycocoating of oligovalent amines: synthesis of thiourea-bridged cluster glycosides from glycosyl isothiocyanates. Agnew. Chem. Internat. Ed. Engl. 35, 1953-1956 (1996).
13. Lindhorst T. K.: Artificial multivalent sugar ligands to understand and manipulate carbohydrate-protein interactions. Host-Guest Chem. 218, 201-235 (2002).
14. Mcfadden D. W., Riggs D. R., Jackson B. J., Vona-Davis L.: Keyhole limpet hemocyanin, a novel immune stimulant with promising anticancer activity in Barrett's oesophageal adenocarcinoma. Am. J. Surg. 186, 552-555 (2003).
15. Mcfadden D. W., Riggs D. R., Jackson B. J., Ng A., Cunningham C.: Keyhole limpet hemocyanin potentiates standard immunotherapy for melanoma. Am. J. Surg. 193, 284-287 (2007).
16. Pospisil M., Vannucci L., Fiserova A., Sadalapure K., Krausova K., Horvath O., Kren V., Mosca F., Lindhorst T. K., Bezouska K.: Glycodendrimeric ligands of C-type lectin receptors as therapeutic agents in experimental cancer. Adv. Exp Med. Biol. 495, 343-348 (2001).
17. Riggs D. R., Jackson B. S., Vona-Davis L., Mcfadden D.: In vitro anticancer effects of a novel immunostimulant: keyhole limpet hemocyanin. J. Surg. Res. 108, 279-284 (2002).
18. Rizvi I., Riggs D. R., Jakson B. J., Mcfadden D. W.: Keyhole limpet hemocyanin: An effective adjunct against melanoma in vivo. Am. J. Surg. 194, 628-632 (2007).
19. Vannucci L., Fiserova A., Sadalapure K., Lindhorst T. K., Kuldova M., Rossman P., Horvath O., Kren V., Krist P., Bezouska K., Luptovcova M., Mosca F., Pospisil M.: Effects of N-acetyl-glucosamine-coated glycodendrimers as biological modulators in the B16F10 melanoma model in vivo. Internat. J. Oncol. 23, 285-296 (2003).